Ivantis Seals $17M For Glaucoma Treatment
Ivantis, a developer of a glaucoma treatment, has raised $17 million in new funding from New Enterprise Associates and Delphi Ventures. The money, a second round for Ivantis, will be used for clinical trials of the company’s medial device.
27 June 2011•3 mins read
